VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,051,616 | +70195.2% | 39,079 | -15.5% | 0.03% | -31.2% |
| Q1 2023 | $1,496 | -10.7% | 46,245 | -20.9% | 0.05% | -30.4% |
| Q4 2022 | $1,675 | -99.2% | 58,457 | +536.9% | 0.07% | +1625.0% |
| Q3 2022 | $221,000 | +513.9% | 9,179 | +600.2% | 0.00% | +300.0% |
| Q2 2022 | $36,000 | -29.4% | 1,311 | -1.3% | 0.00% | – |
| Q1 2022 | $51,000 | -98.7% | 1,328 | -98.9% | 0.00% | -100.0% |
| Q4 2021 | $3,917,000 | +79.5% | 122,289 | +65.2% | 0.07% | +21.4% |
| Q3 2021 | $2,182,000 | +1.7% | 74,029 | +17.2% | 0.06% | 0.0% |
| Q2 2021 | $2,146,000 | -81.4% | 63,164 | -82.2% | 0.06% | -71.1% |
| Q1 2021 | $11,523,000 | +287975.0% | 354,560 | +361695.9% | 0.19% | – |
| Q4 2020 | $4,000 | -96.5% | 98 | -96.7% | 0.00% | -100.0% |
| Q3 2020 | $115,000 | +11400.0% | 2,949 | +16283.3% | 0.00% | – |
| Q2 2020 | $1,000 | -100.0% | 18 | -100.0% | 0.00% | -100.0% |
| Q1 2020 | $11,511,000 | +383600.0% | 499,579 | +499479.0% | 0.70% | – |
| Q4 2019 | $3,000 | -100.0% | 100 | -100.0% | 0.00% | -100.0% |
| Q3 2019 | $7,036,000 | +1.2% | 263,406 | -3.2% | 0.48% | +2.8% |
| Q2 2019 | $6,956,000 | +695500.0% | 272,144 | +453473.3% | 0.47% | – |
| Q1 2019 | $1,000 | -100.0% | 60 | -100.0% | 0.00% | -100.0% |
| Q4 2018 | $3,791,000 | -38.9% | 179,735 | -46.4% | 0.27% | -40.0% |
| Q3 2018 | $6,209,000 | +12318.0% | 335,299 | +14976.4% | 0.46% | +15066.7% |
| Q2 2018 | $50,000 | -99.6% | 2,224 | -99.6% | 0.00% | -99.7% |
| Q1 2018 | $11,301,000 | +22058.8% | 514,147 | +23270.3% | 0.97% | +13728.6% |
| Q4 2017 | $51,000 | -97.4% | 2,200 | -97.4% | 0.01% | -95.6% |
| Q3 2017 | $1,935,000 | +38600.0% | 84,267 | +36066.1% | 0.16% | +15900.0% |
| Q2 2017 | $5,000 | -79.2% | 233 | -78.1% | 0.00% | -50.0% |
| Q1 2017 | $24,000 | -50.0% | 1,062 | -53.7% | 0.00% | -60.0% |
| Q4 2016 | $48,000 | -63.9% | 2,294 | -54.5% | 0.01% | -61.5% |
| Q3 2016 | $133,000 | -91.8% | 5,045 | -91.4% | 0.01% | -91.6% |
| Q2 2016 | $1,621,000 | – | 58,506 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |